This study investigates advanced solid tumors. It will explore the effects of an investigational medication, which is a farnesyltransferase inhibitor (FTI), when used alone or with other treatments.
The focus is to evaluate the safety and overall effects of the investigational medication on patients with advanced solid tumors. The study will look at how well the medication is tolerated and its potential impacts.
- Who can participate: Adults aged 18 and older with specific types of advanced solid tumors can join. Participants need to have measurable disease and meet health criteria, such as certain genetic mutations, performance status, and organ function.
- Study details: Participants will receive either the investigational medication alone or in combination with other treatments. In some cases, a placebo might be used.
How understandable was the trial content above?
Hard to understand
Easy to understand